LGD-4033 (Ligandrol)

LGD4033, also known as Ligandrol, is a Selective Androgen Receptor Modulator (SARM) that binds to androgen receptors in muscle and bone with high affinity. It was originally developed to treat muscle wasting and osteoporosis. For performance users, it occupies a specific niche between traditional injectables and harsh oral steroids. One of its primary mechanisms is the suppression of Sex Hormone Binding Globulin (SHBG), which increases the amount of free testosterone available in the bloodstream, effectively making a concurrent base of testosterone more potent.

The effects of the compound typically take 2 to 3 weeks to manifest, it's often said to be slightly weaker than mild oral steroids like Anavar. it is effective at preserving lean tissue during a steep caloric deficit. Some individuals utilize it as a kick start to a longer injectable cycle or as a way to increase work capacity without the gastric distress or gym cramps often caused by harsher orals. Because it does not aromatize into estrogen, it is frequently used by those who want to avoid the water retention and bloating seen with traditional bulking agents.

Dosing protocols generally center around 5 mg to 10 mg per day, with 10 mg being considered the sweet spot for most individuals. While some athletes push the dose to 20 mg, this often leads to painfully intense muscle pumps and increased lethargy. Despite early marketing claims that SARMs are non suppressive, Ligandrol causes significant HPTA suppression that can drop natural testosterone levels substantially. This makes a testosterone base or a thorough post cycle therapy plan essential for those who want to maintain their gains and avoid a hormonal crash.

Side effects are generally manageable but can include elevated liver enzymes, night sweats, insomnia, and a slight increase in blood pressure. Because it suppresses SHBG, users stacking it with testosterone may notice a faster onset of estrogen related side effects.